Anonymous
Not logged in
Talk
Contributions
Create account
Log in
Search
Editing
Hélène Cabanas
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Namespaces
Page
Discussion
More
More
Page actions
Read
Edit
Edit source
History
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
{{NeedsImage}} '''Hélène Cabanas''', PhD, is a Cell physiologist participating in a post-doctorate fellowship at the School of Medical Sciences, Griffith Health, Griffith University, [[Australia]].<ref>{{Cite web | url = https://www.linkedin.com/in/hélène-cabanas-04a412116/ | title = Hélène Cabanas | last = | first = | authorlink = | date = | website = LinkedIn|archive-url=|archive-date=|url-status=|access-date=2019-10-21}}</ref> She is a member of the [[National Centre for Neuroimmunology and Emerging Diseases|National Centre for Neuroimmunology and Emerging Disease]] (NCNED), an [[Australia|Australian]] research group led by Professors [[Sonya Marshall-Gradisnik]] and [[Donald Staines]].<ref name=":0">{{Cite web | url = https://www.griffith.edu.au/menzies-health-institute-queensland/about-menzieshiq/Infectious-Diseases-and-Immunology/neuroimmunology-and-emerging-diseases | title = National Centre for Neuroimmunology and Emerging Diseases | website = griffith.edu.au|language=en|access-date=2019-10-21}}</ref> Her research focuses on cellular calcium pathway signalling and their implications in physiological and pathophysiological processes in hopes of understanding the pathomechanism of Chronic Fatigue Syndrome / Myalgic Encephalomyelitis (CFS/ME).<ref name=":0" /> ==Notable studies== *2021, Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment<ref name="Cabanas2021">{{Cite journal | title = Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment | date = 2021 | url=https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806|journal=Frontiers in Immunology|volume=12|issue= | pages = 687806 | last = Cabanas | first = Helene | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | authorlink2 = | last3 = Eaton-Fitch | first3 = Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Staines | first4 = Donald Ross | authorlink4 = Donald Staines | last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik|doi=10.3389/fimmu.2021.687806|pmc=PMC8313851|pmid=34326841|access-date=|issn=1664-3224|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806/full (Full text)] *2021, Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref name="Maksoud2021">{{Cite journal | last = Maksoud | first = Rebekah | authorlink = | last2 = Eaton-Fitch | first2 = Natalie | authorlink2 = Natalie Eaton-Fitch | last3 = Matula | first3 = Michael | authorlink3 = | last4 = Cabanas | first4 = Hélène | authorlink4 = Hélène Cabanas | last5 = Staines | first5 = Donald | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = May 2021 | title = Systematic Review of Sleep Characteristics in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | url = https://www.mdpi.com/2227-9032/9/5/568|journal=Healthcare|language=en|volume=9|issue=5 | pages = 568|doi=10.3390/healthcare9050568|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.mdpi.com/2227-9032/9/5/568 (Full text)] * 2019, Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients<ref>{{Cite journal | last = Cabanas | first = H. | authorlink = Hélène Cabanas | last2 = Muraki | first2 = K. | authorlink2 = | last3 = Balinas | first3 = C. | authorlink3 = | last4 = Eaton-Fitch | first4 = N. | authorlink4 = Natalie Eaton-Fitch | last5 = Staines | first5 =D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | date = Dec 2019 | title = Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis patients | url = https://molmed.biomedcentral.com/articles/10.1186/s10020-019-0083-4|journal=Molecular Medicine|language=en|volume=25|issue=1|pages=|doi=10.1186/s10020-019-0083-4|issn=1076-1551|quote=|via=}}</ref> - [https://link.springer.com/article/10.1186/s10020-019-0083-4 (Full text)] * 2019, A systematic review of [[Cytokine|cytokines]] in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID)<ref>{{Cite journal | last = Corbitt | first = Matthew | authorlink = | last2 = Eaton-Fitch | first2 = Natalie | authorlink2 = Natalie Eaton-Fitch | last3 = Staines | first3 = Donald | authorlink3 = Donald Staines | last4 = Cabanas | first4 = Hélène | authorlink4 = Hélène Cabanas | last5 = Marshall-Gradisnik | first5 = Sonya | authorlink5 = Sonya Marshall-Gradisnik | date = Dec 2019 | title = A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID) | url = https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-019-1433-0|journal=BMC Neurology|language=en|volume=19|issue=1|pages=|doi=10.1186/s12883-019-1433-0|issn=1471-2377|pmc=|pmid=31445522|access-date=|quote=|via=}}</ref> - [https://link.springer.com/article/10.1186/s12883-019-1433-0#citeas (Full text)] * 2019, [[Low dose naltrexone|Naltrexone]] restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients<ref>{{Cite journal | last = Cabanas | first = Helene | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | authorlink2 = | last3 = Staines | first3 = Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik | date = 14 Oct 2019 | title = Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients | url = https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract|journal=Frontiers in Immunology|volume=|issue=|pages=|doi=10.3389/fimmu.2019.02545|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [https://www.frontiersin.org/articles/10.3389/fimmu.2019.02545/abstract (Abstract)] *2019, [[Transient receptor potential melastatin 2]] channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients<ref name="Balinas2019">{{Cite journal | last = Balinas | first = Cassandra | authorlink = Cassandra Balinas | last2 = Cabanas | first2 = Hélène | authorlink2 = Hélène Cabanas | last3 = Staines | first3 = Donald | authorlink3 = Donald Staines | last4 = Marshall-Gradisnik | first4 = Sonya | authorlink4 = Sonya Marshall-Gradisnik | date = 2019-12-03 | title = Transient receptor potential melastatin 2 channels are overexpressed in myalgic encephalomyelitis/chronic fatigue syndrome patients | url = https://doi.org/10.1186/s12967-019-02155-4|journal=Journal of Translational Medicine|volume=17|issue=1 | pages = 401|doi=10.1186/s12967-019-02155-4|issn=1479-5876|pmc = 6891975|pmid=31796045|access-date=|quote=|via=}}</ref> - [https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-019-02155-4 (Full text)] * 2018, Decreased Expression of [[Transient receptor potential melastatin 3|TRPM3]] and [[muscarinic acetylcholine M3 receptor|mAChRM3]] in the Small Intestine in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]]<ref name="Gradisnik2018">{{Cite journal | last = Marshall-Gradisnik | first = Sonya | authorlink = Sonya Marshall-Gradisnik | last2 = Fretel | first2 = Marshall | authorlink2 = | last3 = Eaton | first3 = Natalie | authorlink3 = Natalie Eaton-Fitch | last4 = Cabanas | first4 = Helene | authorlink4 = Hélène Cabanas | last5 = Balinas | first5 = Cassandra | authorlink5 = Cassandra Balinas | last6 = Gopalan | first6 = Vinod | last7 = Petersen | first7 = Daniel | authorlink7 = Daniel Peterson | last8 = Passmore | first8 = Rachel | last9 = Tang | first9 = Kevin | last10 = Haque | first10 = Mazhar | authorlink10 = | last11 = Lam | first11 = Alfred | authorlink11 = | last12 = Staines | first12 = Donald | authorlink12 = Donald Staines | date = 2018-05-31 | title = Decreased Expression of TRPM3 and mAChRM3 in the Small Intestine in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis | url = http://www.scirp.org/journal/PaperInformation.aspx?PaperID=85005&#abstract|journal=International Journal of Clinical Medicine|language=en|volume=09|issue=05 | pages = 467|doi=10.4236/ijcm.2018.95040 | via = | pmc = | pmid = | quote = | access-date = }}</ref> - [http://file.scirp.org/Html/11-2101759_85005.htm (Full text)] * 2018, A systematic review of enteric [[dysbiosis]] in chronic fatigue syndrome/myalgic encephalomyelitis<ref>{{Cite journal | last = Du Preez | first = S. | authorlink = | last2 = Corbitt | first2 = M. | authorlink2 = | last3 = Cabanas | first3 = H. | authorlink3 = Hélène Cabanas | last4 = Eaton | first4 = N. | authorlink4 = Natalie Eaton-Fitch | last5 = Staines | first5 =D. | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = S. | authorlink6 = Sonya Marshall-Gradisnik | date = 2018-12-20 | title = A systematic review of enteric dysbiosis in chronic fatigue syndrome/myalgic encephalomyelitis | url = https://doi.org/10.1186/s13643-018-0909-0|journal=Systematic Reviews|volume=7|issue=1 | pages = 241|doi=10.1186/s13643-018-0909-0|issn=2046-4053|pmc=|pmid=30572962|quote=|via=}}</ref> - [https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-018-0909-0 (Full text)] * 2018, [[Rituximab]] impedes [[natural killer cell]] function in [[ME/CFS|Chronic Fatigue Syndrome/Myalgic Encephalomyelitis]] patients: A pilot in vitro investigation<ref>{{Cite journal | title = Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation | url = https://bmcpharmacoltoxicol.biomedcentral.com/articles/10.1186/s40360-018-0203-8|journal=BMC Pharmacology and Toxicology | date = Dec 2018|issn=2050-6511|pmc=5870391|pmid=29587879|pages=12|volume=19|issue=1|doi=10.1186/s40360-018-0203-8|language=en | first = Natalie | last = Eaton | first2 = Hélène | last2 = Cabanas | first3 = Cassandra | last3 = Balinas | first4 = Anne | last4 = Klein | first5 = Donald | last5 = Staines | first6 = Sonya | last6 = Marshall-Gradisnik | author-link = | author-link2 = Hélène Cabanas|access-date= | authorlink3 = | authorlink4 = | authorlink5 = Donald Staines | authorlink6 = Sonya Marshall-Gradisnik|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870391/ (Full Text)] * 2018, Loss of [[transient receptor potential melastatin 3|Transient Receptor Potential Melastatin 3]] ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients<ref>{{Cite journal | last = Cabanas | first = Hélène | authorlink = Hélène Cabanas | last2 = Muraki | first2 = Katsuhiko | last3 = Eaton | first3 = Natalie | last4 = Balinas | first4 = Cassandra | last5 = Staines | first5 = Donald | authorlink5 = Donald Staines | last6 = Marshall-Gradisnik | first6 = Sonya | authorlink6 = Sonya Marshall-Gradisnik | date = 2018-08-14 | title = Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients | url = https://molmed.biomedcentral.com/articles/10.1186/s10020-018-0046-1|journal=Molecular Medicine|language=en|volume=24|issue=1|pages=|doi=10.1186/s10020-018-0046-1|issn=1076-1551|via=}}</ref> - [https://molmed.biomedcentral.com/articles/10.1186/s10020-018-0046-1 (Full Text)] ==Talks and interviews== ==Online presence== ==See also== *[[Transient receptor potential melastatin 3]] *[[Ion channel]] ==Learn more== ==References== {{reflist}} [[Category:Researchers]] [[Category:Australia researchers]]
Summary:
Please make sure your edits are consistent with
MEpedia's guidelines
.
By saving changes, you agree to the
Terms of use
, and you irrevocably agree to release your contribution under the
CC BY-SA 3.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)
Templates used on this page:
Template:Cite journal
(
edit
)
Template:Cite web
(
edit
)
Template:Main other
(
edit
)
Template:NeedsImage
(
edit
)
Template:Reflist
(
edit
)
Module:Check for unknown parameters
(
edit
)
Module:Citation/CS1
(
edit
)
Module:Citation/CS1/COinS
(
edit
)
Module:Citation/CS1/Configuration
(
edit
)
Module:Citation/CS1/Date validation
(
edit
)
Module:Citation/CS1/Identifiers
(
edit
)
Module:Citation/CS1/Utilities
(
edit
)
Module:Citation/CS1/Whitelist
(
edit
)
Module:No globals
(
edit
)
This page is a member of a hidden category:
Category:Articles that need an image or photo
Navigation
Navigation
Skip to content
Main page
Browse
Become an editor
Random page
Popular pages
Abbreviations
Glossary
About MEpedia
Links for editors
Contents
Guidelines
Recent changes
Pages in need
Search
Help
Wiki tools
Wiki tools
Special pages
Page tools
Page tools
User page tools
More
What links here
Related changes
Page information
Page logs